Skip to main content
Caplight Logo









Vital Bio

Vital Bio

Private
TorontoHealthcare & Life Scienceshttps://vitalbio.com/

Last Round

Series A

Jul 24, 2023

Total Funding Raised

$77.44M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Vital Bio is a healthcare technology company that develops advanced diagnostic solutions, including the VitalOne point-of-care platform, to enhance the personalization, accessibility, and effectiveness of medical care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Healthcare Analytics, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

point-of-care diagnosticsPOC testingblood testing deviceclinical laboratorymedical devicemicrofluidicsdiagnostic platformautomated blood analysislab-on-a-chipclinical workflow integrationdiagnostic consumablescomputer vision diagnosticsdecentralized diagnosticsrapid blood testinghealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vital Bio Comparables

Compare Vital Bio with similar companies based on industry and business-model similarity.

Vital Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Truvian
89%
Chronus Health
83%
Instadiagnostics, Inc.
81%

Vital Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 24, 2023
SeedOct 1, 2019

Key People

Founding team and executive leadership

Vasu Nadella

Co-Founder, CEO

Founding Team

Vital Bio Investors

Notable investors and investment history

Vital Bio investors
InvestorRounds
Forefront Venture PartnersSeries A
Inovia CapitalSeries A, Early Funding, Seed
Stanford UniversitySeries A
BrightEdgeSeries A
Northpond VenturesSeries A
NEXT VENTŪRESSeries A
Route 66 VenturesSeries A, Early Funding, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 43% MoM.

  • Apr 1, 2026

    Transitioning from pre-revenue to active manufacturing and commercial production.

Vital Bio Filings

Explore SEC and related filing metadata, where available.

Vital Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vital Bio's valuation, stock price, and market status.

Is Vital a public or private company?

Vital is a private company.

What is the current stock price of Vital?

Vital is a private company with no public stock price. No recent secondary market data is available.

How much is Vital worth (valuation)?

Valuation information for Vital is not publicly available.

Can I buy Vital stock?

Vital shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vital's last funding round?

Vital's most recent funding round was Series A on July 24, 2023.

Who are the main investors in Vital?

Key investors in Vital include Northpond Ventures, Leerink Transformation Partners.

Will Vital IPO soon?

No public IPO plans have been announced for Vital.

How can I track Vital secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vital's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersToronto
Employee Range227
Year Founded2019
Last FundingJul 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?